Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2005-11-16 15:48:42 UTC
Update Date2023-02-21 17:15:22 UTC
HMDB IDHMDB0000985
Secondary Accession Numbers
  • HMDB0006948
  • HMDB00985
  • HMDB06948
Metabolite Identification
Common NameDihydrolipoamide
DescriptionDihydrolipoamide is an intermediate in glycolysis/gluconeogenesis, citrate cycle (TCA cycle), alanine, aspartate and pyruvate metabolism, and valine, leucine and isoleucine degradation (KEGG ID C00579). It is converted to lipoamide via the enzyme dihydrolipoamide dehydrogenase [EC:1.8.1.4]. Dihydrolipoamide is also a substrate of enzyme Acyltransferases [EC 2.3.1.-]. (KEGG).
Structure
Data?1676999722
Synonyms
ValueSource
6,8-DimercaptooctanamideChEBI
DihydrothioctamideChEBI
6,8-Bis-sulfanyloctanamideHMDB
6,8-Dimercapto-octanamideHMDB
6,8-DisulfanyloctanamideHMDB
Dihydrolipoamide, (+-)-isomerHMDB
Chemical FormulaC8H17NOS2
Average Molecular Weight207.357
Monoisotopic Molecular Weight207.075155551
IUPAC Name6,8-disulfanyloctanimidic acid
Traditional Namedihydrothioctamide
CAS Registry Number3884-47-7
SMILES
OC(=N)CCCCC(S)CCS
InChI Identifier
InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)
InChI KeyVLYUGYAKYZETRF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as fatty amides. These are carboxylic acid amide derivatives of fatty acids, that are formed from a fatty acid and an amine.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty amides
Direct ParentFatty amides
Alternative Parents
Substituents
  • Fatty amide
  • Primary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid derivative
  • Alkylthiol
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
Biological locationRoute of exposureSource
Process
Naturally occurring process
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.099 g/LALOGPS
logP2.22ALOGPS
logP1.44ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)6.68ChemAxon
pKa (Strongest Basic)8.78ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area44.08 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity68.7 m³·mol⁻¹ChemAxon
Polarizability23.77 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+146.92831661259
DarkChem[M-H]-142.64131661259
AllCCS[M+H]+145.29732859911
AllCCS[M-H]-150.97632859911
DeepCCS[M+H]+148.34730932474
DeepCCS[M-H]-145.93130932474
DeepCCS[M-2H]-181.50430932474
DeepCCS[M+Na]+156.71430932474
AllCCS[M+H]+145.332859911
AllCCS[M+H-H2O]+141.832859911
AllCCS[M+NH4]+148.532859911
AllCCS[M+Na]+149.532859911
AllCCS[M-H]-151.032859911
AllCCS[M+Na-2H]-152.932859911
AllCCS[M+HCOO]-155.132859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.3.73 minutes32390414
Predicted by Siyang on May 30, 202211.9669 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.66 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid28.9 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2509.4 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid340.6 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid135.5 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid201.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid240.4 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid444.5 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid563.8 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)319.7 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid995.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid352.6 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1164.0 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid300.6 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid306.2 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate430.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA458.8 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water129.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
DihydrolipoamideOC(=N)CCCCC(S)CCS3229.4Standard polar33892256
DihydrolipoamideOC(=N)CCCCC(S)CCS1863.1Standard non polar33892256
DihydrolipoamideOC(=N)CCCCC(S)CCS1961.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Dihydrolipoamide,1TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(S)CCS2065.0Semi standard non polar33892256
Dihydrolipoamide,1TMS,isomer #2C[Si](C)(C)SC(CCS)CCCCC(=N)O2131.6Semi standard non polar33892256
Dihydrolipoamide,1TMS,isomer #3C[Si](C)(C)SCCC(S)CCCCC(=N)O2174.0Semi standard non polar33892256
Dihydrolipoamide,1TMS,isomer #4C[Si](C)(C)N=C(O)CCCCC(S)CCS2047.1Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C2177.3Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C2113.2Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C2586.3Standard polar33892256
Dihydrolipoamide,2TMS,isomer #2C[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C2230.3Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #2C[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C2123.6Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #2C[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C2676.7Standard polar33892256
Dihydrolipoamide,2TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C2062.2Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C1996.1Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C2497.1Standard polar33892256
Dihydrolipoamide,2TMS,isomer #4C[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C2258.7Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #4C[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C2168.5Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #4C[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C2815.7Standard polar33892256
Dihydrolipoamide,2TMS,isomer #5C[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C2122.2Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #5C[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C2067.0Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #5C[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C2578.5Standard polar33892256
Dihydrolipoamide,2TMS,isomer #6C[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C2179.7Semi standard non polar33892256
Dihydrolipoamide,2TMS,isomer #6C[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C2084.0Standard non polar33892256
Dihydrolipoamide,2TMS,isomer #6C[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C2668.2Standard polar33892256
Dihydrolipoamide,3TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2300.1Semi standard non polar33892256
Dihydrolipoamide,3TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2304.3Standard non polar33892256
Dihydrolipoamide,3TMS,isomer #1C[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2556.8Standard polar33892256
Dihydrolipoamide,3TMS,isomer #2C[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C)O[Si](C)(C)C2142.2Semi standard non polar33892256
Dihydrolipoamide,3TMS,isomer #2C[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C)O[Si](C)(C)C2188.2Standard non polar33892256
Dihydrolipoamide,3TMS,isomer #2C[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C)O[Si](C)(C)C2399.1Standard polar33892256
Dihydrolipoamide,3TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C)O[Si](C)(C)C2189.1Semi standard non polar33892256
Dihydrolipoamide,3TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C)O[Si](C)(C)C2175.1Standard non polar33892256
Dihydrolipoamide,3TMS,isomer #3C[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C)O[Si](C)(C)C2499.8Standard polar33892256
Dihydrolipoamide,3TMS,isomer #4C[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2259.4Semi standard non polar33892256
Dihydrolipoamide,3TMS,isomer #4C[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2267.0Standard non polar33892256
Dihydrolipoamide,3TMS,isomer #4C[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C2657.9Standard polar33892256
Dihydrolipoamide,4TMS,isomer #1C[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C)O[Si](C)(C)C2286.9Semi standard non polar33892256
Dihydrolipoamide,4TMS,isomer #1C[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C)O[Si](C)(C)C2334.0Standard non polar33892256
Dihydrolipoamide,4TMS,isomer #1C[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C)S[Si](C)(C)C)O[Si](C)(C)C2297.1Standard polar33892256
Dihydrolipoamide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(S)CCS2309.4Semi standard non polar33892256
Dihydrolipoamide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)SC(CCS)CCCCC(=N)O2343.2Semi standard non polar33892256
Dihydrolipoamide,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)SCCC(S)CCCCC(=N)O2396.0Semi standard non polar33892256
Dihydrolipoamide,1TBDMS,isomer #4CC(C)(C)[Si](C)(C)N=C(O)CCCCC(S)CCS2264.5Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2662.6Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2532.3Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2712.0Standard polar33892256
Dihydrolipoamide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2720.4Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2542.8Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=N)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2810.6Standard polar33892256
Dihydrolipoamide,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C(C)(C)C2508.3Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C(C)(C)C2379.4Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS)O[Si](C)(C)C(C)(C)C2687.1Standard polar33892256
Dihydrolipoamide,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C(C)(C)C2749.4Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C(C)(C)C2621.8Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)SCCC(CCCCC(=N)O)S[Si](C)(C)C(C)(C)C2836.7Standard polar33892256
Dihydrolipoamide,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2619.6Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2479.4Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS)S[Si](C)(C)C(C)(C)C2734.8Standard polar33892256
Dihydrolipoamide,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2662.3Semi standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2502.8Standard non polar33892256
Dihydrolipoamide,2TBDMS,isomer #6CC(C)(C)[Si](C)(C)N=C(O)CCCCC(S)CCS[Si](C)(C)C(C)(C)C2824.3Standard polar33892256
Dihydrolipoamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C3036.8Semi standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C2909.2Standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=N)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C2767.0Standard polar33892256
Dihydrolipoamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2858.6Semi standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2740.4Standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2664.6Standard polar33892256
Dihydrolipoamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2905.5Semi standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2741.5Standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)N=C(CCCCC(S)CCS[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2761.3Standard polar33892256
Dihydrolipoamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C2977.2Semi standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C2858.0Standard non polar33892256
Dihydrolipoamide,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N=C(O)CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C2840.7Standard polar33892256
Dihydrolipoamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C3226.2Semi standard non polar33892256
Dihydrolipoamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2986.5Standard non polar33892256
Dihydrolipoamide,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N=C(CCCCC(CCS[Si](C)(C)C(C)(C)C)S[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C2688.1Standard polar33892256
Spectra
Biological Properties
Cellular Locations
  • Mitochondria
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB022352
KNApSAcK IDNot Available
Chemspider ID643
KEGG Compound IDC00579
BioCyc IDNot Available
BiGG ID35406
Wikipedia LinkDihydrolipoamide
METLIN ID5920
PubChem Compound663
PDB IDNot Available
ChEBI ID17694
Food Biomarker OntologyNot Available
VMH IDDHLAM
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceWeitzman, P. D. J.; Hewson, Janet K.; Parker, M. G. Preparation of dihydrolipoamide by electrolytic reduction. FEBS Letters (1974), 43(1), 101-3.
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Brautigam CA, Chuang JL, Tomchick DR, Machius M, Chuang DT: Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations. J Mol Biol. 2005 Jul 15;350(3):543-52. [PubMed:15946682 ]
  2. Kim H: Asparagine-473 residue is important to the efficient function of human dihydrolipoamide dehydrogenase. J Biochem Mol Biol. 2005 Mar 31;38(2):248-52. [PubMed:15826505 ]
  3. McMillan PJ, Stimmler LM, Foth BJ, McFadden GI, Muller S: The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenases. Mol Microbiol. 2005 Jan;55(1):27-38. [PubMed:15612914 ]
  4. Li XJ, Grunwald D, Mathieu J, Morel F, Stasia MJ: Crucial role of two potential cytosolic regions of Nox2, 191TSSTKTIRRS200 and 484DESQANHFAVHHDEEKD500, on NADPH oxidase activation. J Biol Chem. 2005 Apr 15;280(15):14962-73. Epub 2005 Jan 31. [PubMed:15684431 ]
  5. Deres P, Halmosi R, Toth A, Kovacs K, Palfi A, Habon T, Czopf L, Kalai T, Hideg K, Sumegi B, Toth K: Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound. J Cardiovasc Pharmacol. 2005 Jan;45(1):36-43. [PubMed:15613977 ]

Enzymes

General function:
Involved in oxidoreductase activity
Specific function:
Lipoamide dehydrogenase is a component of the glycine cleavage system as well as of the alpha-ketoacid dehydrogenase complexes. Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction.
Gene Name:
DLD
Uniprot ID:
P09622
Molecular weight:
54176.91
Reactions
Dihydrolipoamide + NAD → Lipoamide + NADH + Hydrogen Iondetails
General function:
Involved in acyltransferase activity
Specific function:
The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). It contains multiple copies of 3 enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3).
Gene Name:
DLST
Uniprot ID:
P36957
Molecular weight:
48754.87
General function:
Involved in acyltransferase activity
Specific function:
The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of three enzymatic components: branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3).
Gene Name:
DBT
Uniprot ID:
P11182
Molecular weight:
53486.635
General function:
Involved in acyltransferase activity
Specific function:
Not Available
Gene Name:
DLAT
Uniprot ID:
Q86YI5
Molecular weight:
68996.0